Pe. Carreira et al., ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH EOSINOPHILIA MYALGIA ANDTOXIC OIL SYNDROME, Journal of rheumatology, 24(1), 1997, pp. 69-72
Objective, To explore whether antiphospholipid antibodies (aPL) are ma
rkers of vascular related damage or merely evidence of toxic related a
utoimmunity, we investigated the presence of different aPL in patients
with toxic oil syndrome (TOS) and compared the profile with patients
with eosinophilia myalgia syndrome (EMS). Methods, Reactivity against
cardiolipin, P-serine, P-inositol, and P-choline was investigated by E
LISA in the blood of 266 patients with acute and chronic TOS, 25 healt
hy relatives of TOS patients, and 48 patients with EMS. Results, 32% o
f TOS and 13% of EMS patients had IgG antibodies against cardiolipin a
nd other polyanions. 20% of both TOS and EMS patients presented IgM an
tibodies against anionic and zwitterionic phospholipids. 36% of TOS he
althy relatives had IgM antibodies against differently charged phospho
lipids. Among 200 patients with chronic TOS, there was no significant
association between antibodies and clinical manifestations. Conclusion
, aPL with different specificity are present in a high percentage of p
atients with TOS and EMS. The significance of these antibodies remains
unclear.